Lipocine Inc.LPCNNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank49
3Y CAGR-62.6%
5Y CAGR-28.1%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
-62.6%/yr
Quarterly compound
5Y CAGR
-28.1%/yr
Recent deceleration
Percentile
P49
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 2.22% |
| Q3 2025 | -58.29% |
| Q2 2025 | 4.22% |
| Q1 2025 | -215.71% |
| Q4 2024 | 160.08% |
| Q3 2024 | -13.42% |
| Q2 2024 | -203.75% |
| Q1 2024 | 219.05% |
| Q4 2023 | 22.40% |
| Q3 2023 | 21.26% |
| Q2 2023 | 15.74% |
| Q1 2023 | -113.61% |
| Q4 2022 | 42.50% |
| Q3 2022 | -4.98% |
| Q2 2022 | 21.60% |
| Q1 2022 | -143.20% |
| Q4 2021 | 228.85% |
| Q3 2021 | -195.39% |
| Q2 2021 | 41.82% |
| Q1 2021 | -10.25% |
| Q4 2020 | 11.52% |
| Q3 2020 | -2.07% |
| Q2 2020 | -20.82% |
| Q1 2020 | -2.06% |
| Q4 2019 | -18.26% |
| Q3 2019 | -9.36% |
| Q2 2019 | 14.82% |
| Q1 2019 | -34.49% |
| Q4 2018 | 33.54% |
| Q3 2018 | -22.61% |
| Q2 2018 | 26.86% |
| Q1 2018 | 12.82% |
| Q4 2017 | 5.89% |
| Q3 2017 | 2.87% |
| Q2 2017 | -49.76% |
| Q1 2017 | -23.23% |
| Q4 2016 | 37.10% |
| Q3 2016 | 21.77% |
| Q2 2016 | 20.48% |
| Q1 2016 | -123.56% |